| Related Articles |
Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer.
Future Oncol. 2018 Nov 28;:
Authors: Bilgin B, Şendur MA, Hızal M, Akıncı MB, Dede DŞ, Yalçın B
PMID: 30484708 [PubMed - as supplied by publisher]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2AAWc0s
No comments:
Post a Comment